Vanda Pharmaceuticals buy Global_Player
Start price
19.09.24
/
50%
€4.22
Target price
19.09.25
-
Performance (%)
-1.42%
End price
28.09.24
€4.16
Summary
This prediction ended on 28.09.24 with a price of €4.16. With a performance of -1.42%, the BUY prediction by Global_Player finished with a loss. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vanda Pharmaceuticals | 2.623% | 2.623% | 65.608% |
| iShares Core DAX® | 2.554% | -0.112% | 14.995% |
| iShares Nasdaq 100 | 2.742% | -0.470% | 30.954% |
| iShares Nikkei 225® | 6.584% | 3.221% | 49.697% |
| iShares S&P 500 | 1.930% | -0.519% | 24.883% |
According to Global_Player what are the pros and cons of Vanda Pharmaceuticals for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Global_Player for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Buy Vanda Pharmaceuticals